Article

Medicare May Reimburse for Amyloid Imaging Only in Trials


 

References

Although Medicare does not provide health insurance for working adults, such a diagnosis could lead to Medicare disability coverage. “In this case, a [PET amyloid scan] with positive evidence for Alzheimer’s would save everyone a lot of angst and expense, and the patient could be properly managed in terms of disability,” said Dr. Caselli. “Furthermore, young patients with altered mental status may have other serious illnesses, such as autoimmune encephalopathy, so having access to such a scan might save someone trials of steroids or other immunosuppressive agents.”

—Michele G. Sullivan
IMNG Medical News

Pages

Recommended Reading

Glucose, insulin measures unrelated to AD pathology
MDedge Neurology
Metformin bests other antidiabetics in protection from dementia
MDedge Neurology
Aerobic exercise boosts brain power in mild cognitive impairment
MDedge Neurology
Brain volume loss may be greater in type 1 diabetics with microangiopathy
MDedge Neurology
Delaying Retirement May Reduce Risk for Dementia
MDedge Neurology
New and Noteworthy Information—August 2013
MDedge Neurology
COMMENTARY—Impressive Findings Provide Hope for Patients With CAA-ri
MDedge Neurology
Do Autoantibodies Cause Cerebral Amyloid Angiopathy-Related Inflammation?
MDedge Neurology
Learning genetic risk for Alzheimer’s may not be so distressing
MDedge Neurology
Nikos Scarmeas, MD
MDedge Neurology